Immunomedics (IMMU) Misses Q1 EPS by 86c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Net (loss) attributable to Immunomedics, Inc. stockholders: -16.2M
Today's EPS Names:
EACO, FMBH, ITGR, More
Financial Fact:
Net (loss) attributable to Immunomedics, Inc. stockholders: -16.2M
Today's EPS Names:
EACO, FMBH, ITGR, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.97), $0.86 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $690.49 million, versus $741.81 million reported last year.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stagwell Inc (STGW) Tops Q3 EPS by 3c ; Offers Guidance
- Eaco Corporation (EACO) reported Q4 result
- Perella Weinberg Partners (PWP) Tops Q3 EPS by 22c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
